Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment.
Giordano G, Milella M, Landriscina M, Bergamo F, Tirino G, Santaniello A, Zaniboni A, Vasile E, De Vita F, Re GL, Vaccaro V, Giommoni E, Natale D, Conca R, Santini D, Maiorino L, Sanna G, Ricci V, Iop A, Montesarchio V, Procaccio L, Noventa S, Bianco R, Febbraro A, Lonardi S, Tortora G, Sperduti I, Melisi D. Giordano G, et al. Among authors: bianco r. Cancer Med. 2024 Jun;13(12):e7345. doi: 10.1002/cam4.7345. Cancer Med. 2024. PMID: 38924262 Free PMC article.
Real-world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions.
De Falco V, Suarato G, Napolitano R, Argenziano G, Famiglietti V, Amato A, Servetto A, Bianco R, Formisano L, Terrano V, Esposito A, Giugliano MC, Ciardiello D, Ciardiello F, Napolitano S, Troiani T. De Falco V, et al. Among authors: bianco r. Int J Cancer. 2023 Jul 1;153(1):133-140. doi: 10.1002/ijc.34462. Epub 2023 Feb 21. Int J Cancer. 2023. PMID: 36752579
Role of FGFR3 in bladder cancer: Treatment landscape and future challenges.
Ascione CM, Napolitano F, Esposito D, Servetto A, Belli S, Santaniello A, Scagliarini S, Crocetto F, Bianco R, Formisano L. Ascione CM, et al. Among authors: bianco r. Cancer Treat Rev. 2023 Apr;115:102530. doi: 10.1016/j.ctrv.2023.102530. Epub 2023 Feb 28. Cancer Treat Rev. 2023. PMID: 36898352 Free article. Review.
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO).
Speranza D, Sapuppo E, Aprile G, Auriemma A, Bergamo F, Bianco R, Bordonaro R, Brandi G, Brunetti O, Carnaghi C, Ciliberto D, Cinieri S, Corallo S, De Vita F, Di Donato S, Ferraù F, Fornaro L, Barucca V, Giommoni E, Lotesoriere C, Luchini C, Masini C, Niger M, Pisconti S, Rapposelli IG, Rimassa L, Rognone C, Rodriquenz MG, Corsini LR, Santin D, Scarpa A, Scartozzi M, Soto Parra H, Tonini G, Tortora G, Tralongo P, Silvestris N. Speranza D, et al. Among authors: bianco r. Tumori. 2024 Jun;110(3):203-208. doi: 10.1177/03008916231222761. Epub 2024 Feb 7. Tumori. 2024. PMID: 38326240
Prevention of cardiovascular complications in elderly cancer patients.
Topa E, Rizza M, Iengo M, Cuomo A, Cicia L, Di Sarro E, Miccio M, Ciaccio G, Luise MC, Formisano L, Bianco R, Carlomagno C, Picardi M, Martinelli E, Napolitano S, Troiani T, Ferrara N, Abete P, Tocchetti CG, Mercurio V. Topa E, et al. Among authors: bianco r. Vascul Pharmacol. 2024 Jun;155:107354. doi: 10.1016/j.vph.2024.107354. Vascul Pharmacol. 2024. PMID: 38985632 No abstract available.
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.
De Falco V, Napolitano S, Franco R, Zito Marino F, Formisano L, Esposito D, Suarato G, Napolitano R, Esposito A, Caraglia F, Giugliano MC, Cioli E, Famiglietti V, Bianco R, Argenziano G, Ronchi A, Ciardiello D, Nardone V, D'Ippolito E, Del Tufo S, Ciardiello F, Troiani T. De Falco V, et al. Among authors: bianco r. Oncoimmunology. 2024 Aug 26;13(1):2388315. doi: 10.1080/2162402X.2024.2388315. eCollection 2024. Oncoimmunology. 2024. PMID: 39206096 Free PMC article.
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis.
D'Ambrosio S, Salomone F, Vitale F, Avanzo A, Viggiano A, Liguori L, Ferrara R, Nuccio A, Viscardi G, Napolitano F, Santaniello A, Formisano L, Bianco R, Servetto A. D'Ambrosio S, et al. Among authors: bianco r. Eur J Cancer. 2024 Dec;213:115077. doi: 10.1016/j.ejca.2024.115077. Epub 2024 Oct 20. Eur J Cancer. 2024. PMID: 39454538 Free article.
601 results